| First Author | Lötzer K | Year | 2005 |
| Journal | Biochim Biophys Acta | Volume | 1736 |
| Issue | 1 | Pages | 30-7 |
| PubMed ID | 16081317 | Mgi Jnum | J:100528 |
| Mgi Id | MGI:3588805 | Doi | 10.1016/j.bbalip.2005.07.001 |
| Citation | Lotzer K, et al. (2005) The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. Biochim Biophys Acta 1736(1):30-7 |
| abstractText | Leukotrienes (LTs) are powerful inflammatory lipid mediators derived from the 5-lipoxygenase (5-LO) cascade of arachidonic acid. Recent clinical, population genetic, cell biological, and mouse studies indicate participation of the 5-LO pathway in atherogenesis and arterial wall remodeling. 5-LO is expressed by leukocytes including blood monocytes, tissue macrophages, dendritic cells, neutrophils, and mast cells. LTB4 and the cysteinyl LTs LTC4, LTD4, and LTE4, act through two BLT and two cysLT receptors that are differentially expressed on hematopoietic and arterial wall cells. The precise roles of LTs or the LT receptors in cardiovascular physiology remain largely to be explored. In this review, we will discuss what is currently known about the 5-LO atherosclerosis connection. We will attempt to propose strategies to further explore potential links between the 5-LO pathway and blood vessel physiology and disease progression. |
